Prolira signs collaboration with Orion Pharma for sales of DeltaScan in Germany

The companies ORION Pharma and Prolira are excited to announce their sales collaboration agreement that has been signed in June 2021.

Venture Challenge Summer 2021: Meet the Teams!

Last week, the Venture Challenge Summer 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.

Venture Challenge alumnus Prolira successfully completes DeltaStudy

UMC Utrecht carried out an investigator initiated large scale validation study for DeltaScan device performance, collecting data from a wide study population of 434 hospitalized patients, spread over 9 Dutch hospitals and 31 departments.

Nutrileads appoints Erik Dam as CEO to propel the company towards successful commercialization of its lead ingredient BeniCaros

Dutch health ingredients innovator, NutriLeads, announces the appointment of Erik Dam as CEO to lead the company’s transition from a health ingredients innovator to a commercial health ingredients company based on a strong science foundation.

Venture Challenge alumnus Scope wins AtlasInvest Start-Up Award

Scope Biosciences was announced as one of the two winners of the AtlasInvest Entrepreneurship Grant during the F&A Next 
Scope wins AtlasInvest Entrepreneurship Grant

Want to further develop your business skills? Then register for the TAP BioBusiness training programme

Are you a future BioBusiness leader in Life Sciences & Health? Register now for the TAP BioBusiness training programme and benefit from the early bird fee until 1 June 2021!
TAP Early Bird

Venture Challenge Fall 2021 open for applications!

Today the applications for the 26th edition of the Venture Challenge has opened!
Venture Challenge is open for applications

Venture Challenge winner SeraNovo enters into license agreement with Graviton

SeraNovo BV is pleased to announce the closing of a License Agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncology and neuroscience.
SeraNovo Graviton

Venture Challenge alumnus OcellO acquired by Crown Biosciences

Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs, has acquired OcellO B.V., a privately owned contract research organization located in the Netherlands.

AVATAR Zoo announced as winner of the Proefdiervrij Venture Challenge

Stichting Proefdiervrij wants to increase and accelerate the impact of non-animal research on the use of laboratory animals and has therefore organised the first Animal-free Venture Challenge.
AVATAR Zoo announced as winner of the Proefdiervrij Venture Challenge